✕
Login
Register
Back to News
Barclays Maintains Underweight on DexCom, Lowers Price Target to $64
Benzinga Newsdesk
www.benzinga.com
Negative 47.4%
Neg 47.4%
Neu 0%
Pos 0%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment